 Connection
Marc Bonaca to Blood Coagulation Disorders
This is a "connection" page, showing publications Marc Bonaca has written about Blood Coagulation Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.395 |
|
|
|
-
Hess CN, Hsia J, Carroll IA, Nehler MR, Ruf W, Morrow DA, Nicolau JC, Berwanger O, Szarek M, Capell WH, Johri S, Pursley MS, Gupta R, Meehan PS, Franchi F, Effron MB, Marshall D, Graybill CA, Huebler SP, Keuer T, Bristow MR, Bonaca MP. Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial. Arterioscler Thromb Vasc Biol. 2023 08; 43(8):1572-1582.
Score: 0.736
-
Spyropoulos AC, Bonaca MP. Studying the coagulopathy of COVID-19. Lancet. 2022 01 08; 399(10320):118-119.
Score: 0.659
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|